Australia increases product registration fee under new IVD framework
This article was originally published in SRA
Executive Summary
Australian in vitro diagnostic companies wanting to market their products under the newly-enacted IVD framework will have to pay a fee of Aus$790 (US $720) to register their products with the Therapeutic Goods Administration1,2.